{
    "id": 28829,
    "fullName": "JAK3 H583Y",
    "impact": "missense",
    "proteinEffect": "gain of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "JAK3 H583Y lies within the protein kinase domain 1 of the Jak3 protein (UniProt.org). H538Y has not been biochemically characterized, but demonstrates transformation of cells in culture (PMID: 28284718), and therefore, is predicted to lead to a gain of function Jak3 protein function.",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 12375,
                    "pubMedId": 28284718,
                    "title": "Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28284718"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 3718,
        "geneSymbol": "JAK3",
        "terms": [
            "JAK3",
            "JAK-3",
            "JAK3_HUMAN",
            "JAKL",
            "L-JAK",
            "LJAK"
        ]
    },
    "variant": "H583Y",
    "createDate": "10/11/2018",
    "updateDate": "10/18/2019",
    "referenceTranscriptCoordinates": {
        "id": 177557,
        "transcript": "NM_000215",
        "gDna": "chr19:g.17837168G>A",
        "cDna": "c.1747C>T",
        "protein": "p.H583Y",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15051,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Xeljanz (tofacitinib, CP-690,550) decreased cell viability in transformed mouse Ba/F3 cells expressing Jak3 H538Y (PMID: 28284718).",
            "molecularProfile": {
                "id": 30715,
                "profileName": "JAK3 H583Y"
            },
            "therapy": {
                "id": 941,
                "therapyName": "Tofacitinib",
                "synonyms": null
            },
            "indication": {
                "id": 2531,
                "name": "hematologic cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 12375,
                    "pubMedId": 28284718,
                    "title": "Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal Type.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28284718"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 30715,
            "profileName": "JAK3 H583Y",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 177557,
            "transcript": "NM_000215",
            "gDna": "chr19:g.17837168G>A",
            "cDna": "c.1747C>T",
            "protein": "p.H583Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}